From Surf Wiki (app.surf) — the open knowledge base
Parathyroid carcinoma
Cancerous tumor of the parathyroid gland
Cancerous tumor of the parathyroid gland
| Field | Value |
|---|---|
| name | Parathyroid carcinoma |
| image | File:Parathyroid es.svg |
| caption | Parathyroid gland anatomy(green marks) |
| field | Oncology, ENT surgery |
Parathyroid carcinoma is a rare cancer resulting in parathyroid adenoma to carcinoma progression. It forms in tissues of one or more of the parathyroid glands (four pea-sized glands in the neck that make parathyroid hormone (PTH). PTH helps the body maintain normal levels of serum calcium by promoting calcium reabsorption from bone. It is antagonized by the hormone calcitonin, which prompts calcium storage.).
It is rare—with documented cases of less than one thousand since its first discovery in 1904—and much less common than parathyroid adenoma. It can be difficult to excise. The rate of occurrence of parathyroid carcinoma is between 0.5% to 5%.
Signs and symptoms
Most patients experience moderate to severe hypercalcemia and high parathyroid hormone levels. A large mass in the neck is often seen, and kidney and bone abnormalities are common.
Risk factors
Parathyroid cancer occurs in midlife at the same rate in men and women.
Conditions that appear to result in an increased risk of parathyroid cancer include multiple endocrine neoplasia type 1, autosomal dominant familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome (which also is hereditary). Parathyroid cancer has also been associated with external radiation exposure, but most reports describe an association between radiation and the more common parathyroid adenoma.
Diagnosis
On Sestamibi parathyroid scan, intense radioactivity greater than submandibular gland on delayed image, no washout between early and delayed images, and high concentration of parathyroid hormone concentration in blood in those who age more than 40 years is suggestive of parathyroid carcinoma. Some authors suggest high levels of HCG as a marker for parathyroid carcinoma in the right context. However, other thyroid diseases such as multinodular goitre, Hashimoto thyroiditis, thyroid adenoma, and thyroid carcinoma also retains the radiotracer because of high metabolic nature of these diseases. Thus, the final diagnosis always requires pathological examination of the tissue in question.
Treatment
Parathyroid carcinoma is sometimes diagnosed during surgery for primary hyperparathyroidism. If the surgeon suspects carcinoma based on severity or invasion of surrounding tissues by a firm parathyroid tumor, aggressive excision is performed, including the thyroid and surrounding tissues as necessary.
Agents such as calcimimetics (for example, cinacalcet) are used to mimic calcium and are able to activate the parathyroid calcium-sensing receptor (making the parathyroid gland "think" we have more calcium than we actually do), therefore lowering the calcium level, in an attempt to decrease the hypercalcemia.
References
References
- Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. [http://www.cancernetwork.com/cancer-management-11/chapter05/article/10165/1402668 "Thyroid and Parathyroid Cancers"] {{Webarchive. link. (2010-02-28 in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) [http://www.cancernetwork.com/cancer-management-11/ Cancer Management: A Multidisciplinary Approach] {{Webarchive). link. (2013-10-04 . 11 ed. 2008.)
- (August 2010). "Parathyroid carcinoma". Clinical Oncology.
- (March 2012). "Parathyroid carcinoma: update and guidelines for management". Current Treatment Options in Oncology.
- (April 2010). "Parathyroid carcinoma". Otolaryngologic Clinics of North America.
- (August 2004). "Parathyroid carcinoma". Otolaryngologic Clinics of North America.
- (2016-06-01). "Parathyroid Cancer Cases: A Single Center's Experience". AACE Clinical Case Reports.
- (July 2005). "Predicting the presence of parathyroid carcinoma". Annals of Surgical Oncology.
- "Endocrine Pathology".
- (July 1992). "Parathyroid carcinoma: clinical and pathologic features in 43 patients". Medicine.
- (December 2012). "Parathyroid carcinoma: challenges in diagnosis and treatment". Hematology/Oncology Clinics of North America.
- (August 2010). "Parathyroid carcinoma". Clinical Oncology.
- (August 2010). "Parathyroid carcinoma". Clinical Oncology.
- (11 March 2009). "Parathyroid Cancer Treatment". National Cancer Institute.
- (December 2011). "Differential findings of tc-99m sestamibi dual-phase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism". Nuclear Medicine and Molecular Imaging.
- (2018-05-08). "Human Chorionic Gonadotrophin (hCG) as a diagnostic test to differentiate between Parathyroid Carcinoma, Primary Benign Hyperparathyroidism and Secondary Hyperparathyroidism.". Bioscientifica.
- (May 1999). "Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy". Radiographics.
- (9 December 2014). "Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients". John Wiley & Sons, Ltd.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Parathyroid carcinoma — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report